Artelo Biosciences CEO to Speak at Virtual Healthcare Summit
Artelo Biosciences CEO to Speak at Major Healthcare Event
Artelo Biosciences, Inc. (Nasdaq: ARTL), a forward-thinking pharmaceutical company located in Solana Beach, California, focuses on innovative treatments targeting lipid-signaling pathways for a variety of health conditions. The company is at the forefront of developing therapeutic solutions for patients suffering from cancer, chronic pain, and other serious disorders.
Scheduled for October 15-17, 2024, the Maxim Group 2024 Virtual Healthcare Summit is an excellent platform for engaging dialogue and discovery in the healthcare sector. Gregory D. Gorgas, CEO of Artelo Biosciences, will engage in a fireside chat alongside Jason McCarthy, Senior Managing Director and Head of Biotechnology Research at Maxim Group.
Event Focus and Engagement
On October 16, 2024, at 4:00 PM ET, Gorgas will discuss critical insights regarding Artelo's pioneering treatments and their developments aimed at addressing significant unmet medical needs across various disease states. This interactive session signifies the company's commitment to transparency and innovation in the biopharmaceutical space.
Participants can join this enlightening session by registering in advance, allowing them to gain firsthand knowledge about the evolving landscape of oncology and pain management therapies. Artelo’s approach not only highlights their scientific advancements but also emphasizes their strategies for regulatory compliance and market introduction.
Company Overview
Artelo Biosciences is dedicated to commercializing proprietary therapeutic products designed specifically to modulate lipid-signaling pathways. Their mission is to address crucial gaps in treatments for conditions such as anorexia, anxiety, pain, inflammation, and skin disorders. Led by a team of seasoned biopharmaceutical experts, Artelo is advancing its promising pipeline with a blend of robust scientific rigor and innovative approaches.
The company collaborates closely with respected researchers and technology specialists to ensure that their products are backed by solid and cutting-edge scientific research. Their commitment to delivering impactful therapies is evident in their thorough development process, ensuring that they meet the needs of healthcare providers and patients alike.
Contact Information
For those interested in learning more about Artelo Biosciences and their initiatives, Crescendo Communications handles investor relations. Interested parties can get in touch by phone at 212-671-1020 or by email at ARTL@crescendo-ir.com. This support offers insight into the company’s vision and ongoing projects.
Frequently Asked Questions
What is the focus of Artelo Biosciences?
Artelo Biosciences specializes in developing treatments that modulate lipid-signaling pathways to combat various serious health conditions, including cancer and pain.
When will the fireside chat take place?
The chat is scheduled for October 16, 2024, at 4:00 PM ET during the Maxim Group Virtual Healthcare Summit.
How can one register for the event?
Participants can register online to gain access to the webcast of the fireside chat featuring Gregory D. Gorgas.
What are some diseases Artelo aims to address?
Artelo has a strong focus on conditions like cancer, anxiety, pain, anorexia, and dermatological issues.
Who should attend the Maxim Group Virtual Healthcare Summit?
This event is ideal for investors, healthcare professionals, and anyone interested in innovations in pharmaceuticals and healthcare advancements.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Buildkite Unveils Innovative Scale-Out Platform for Enterprises
- Tech Market Trends: Insights into Recent Stock Movements
- LEO Token Sees Significant Growth with 9.26% Surge
- Top Billionaires Offloading Apple Shares: What Investors Should Know
- Henry Earns Recognition as Building Materials Partner of the Year
- Arbele Enhances AI Collaborations to Revolutionize Oncology Therapy
- Decoding Retirement Strategies: Balancing Risks and Rewards
- Sapia.ai Launches Live Interview™ To Simplify High-Volume Hiring
- Willard D Oberton's Recent Insider Transaction: A Closer Look
- Quectel Unveils Innovative Antenna Solutions for IoT Growth
Recent Articles
- IDEX Biometrics ASA's General Meeting Highlights and Decisions
- TD SYNNEX Highlights Growing Demand for AI Solutions Worldwide
- InterVision Earns Cisco Gold Provider Status for Managed Services
- Longeveron's Lomecel-B™ Promises Hope for HLHS Patients
- Monument Advocacy Partners with Everlane to Strengthen Growth
- David Montgomery Inspires Youth Engagement in Scouting Programs
- Understanding Net Asset Value for Octopus AIM VCT plc Shares
- Revolutionizing Healthcare Analytics with AI-Powered Solutions
- project44 Shines Again as Market Leader in G2 Rankings
- Octopus AIM VCT 2 plc Reports Significant Asset Value Update
- Naomi Osaka Joins Maybelline's Brave Together Initiative
- Revolutionary Event Store Cloud Launches on AWS Marketplace
- CeMat A/S Strengthens Portfolio with New Land Acquisition
- Guild's Game-Changing Acquisition: The Future of Talent Development
- JLL to Host Third Quarter Earnings Call—Key Details Inside
- BMC's Strategic Decision to Form Two Independent Entities
- Mytra Strengthens Leadership Team to Propel Robotics Innovation
- Juice Plus+ Stands Strong with St. Jude Memphis Marathon
- Empowering Healthcare Leaders: The Launch of Leader Inspired Work
- CRISP & GREEN® Unveils Fall Menu with Exciting New Flavors
- Wilson Connectivity Launches Innovative Private 5G Solutions
- Lendbuzz Concludes Major $262 Million Securitization Deal
- Chewy's Growth Prospects Shine with Buy Rating from TD Cowen
- Harris Edges Ahead of Trump in an Intensifying Presidential Race
- Meeting the Challenges: Insights from Finance Professionals
- Revamping Wealth Management: BetaNXT's Corporate Actions
- Kronos Bio Unveils Promising Data on HPV Tumor Therapy
- Stifel's Strategic Insights on Leading European Delivery Firms
- EBIN New York Launches Innovative Wonder Weave Bond Collection
- UBS Predicts Continued Gold Rally: What to Expect
- Honda Faces Significant Vehicle Recall Due to Defective Gearbox
- Transforming Insurance: Eastern Alliance's Success with AI
- Critical Financial Stocks to Watch This October
- ClearSign Technologies Eyes Growth with New Power Plant Order
- Latest Insights on Stocks: PayPal, Las Vegas Sands, and More
- Exciting New Entertainment Destination Opens Soon in Texas
- Gilead Sciences Unveils Groundbreaking Antiviral Research
- Exciting Reimagined Experience Awaits at Dave & Buster's
- Aspen Aerogels Navigates Market Shifts with Resilience
- Dave & Buster's Unveils Exciting New Store Concept Soon
- Meta Platforms Seeing Growth with Bullish Analyst Ratings
- Helmerich & Payne Enhances Financial Position with Sale
- BuzzRx® Shares Key Health Insights for Awareness Month
- Pringles Dill Pickle Returns Amidst Rising Snack Trends
- Baird Medical Begins Trading on Nasdaq Under 'BDMD' Ticker
- Tansect Unveils Innovative SaaS Platforms and Achievements
- Momentus Secures NASA Contract to Launch Advanced Satellite Services
- ProofPilot Strengthens Advisory Board with Roslyn Schneider
- Citi Rates Canadian Pacific Kansas City as a Strong Buy
- HighByte Unveils Next-Gen DataOps Solution for Manufacturers